AMN Healthcare: Capitalizing on the Inflection in Workforce Solutions

Kyle Mowery of GrizzlyRock Capital presented his in-depth investment thesis on AMN Healthcare Services (US: AMN) at Best Ideas 2026.

Thesis summary:

AMN is the largest diversified healthcare staffing provider in the U.S., offering a comprehensive suite of workforce solutions that includes nurse and allied staffing, physician placement, and technology-driven workforce management. The company operates in a cyclical industry that is currently emerging from a post-COVID trough, a period characterized by compressed bill-pay spreads as healthcare systems shifted toward permanent labor to rationalize costs. Recent data indicates an inflection point; demand for travel nurses has rebounded approximately 50% from mid-2025 lows, and bill rates have stabilized with early signs of improvement. AMN’s scale, combined with its integrated technology platform, positions it advantageously against smaller competitors and “tech-native” entrants that have struggled with profitability and fulfillment during the downturn.

Long-term demand is supported by robust secular tailwinds, specifically an aging demographic driving higher healthcare utilization against a backdrop of persistent shortages in clinical labor. AMN has strategically diversified its revenue mix, reducing reliance on traditional staffing by expanding into high-margin technology and workforce solutions which enhance client retention. While the upcoming renewal of the Kaiser contract—historically representing a notable portion of revenue—creates a perceived overhang, the depth of the relationship suggests a high probability of renewal. Furthermore, a growing pipeline of vendor management system (VMS) and managed service provider (MSP) opportunities in late 2026 offers additional avenues for margin expansion and revenue growth largely ignored by current street estimates.

Financially, AMN remains highly cash-generative throughout the cycle, averaging robust FCF even prior to its recent expansion into higher-margin segments. Although headline leverage appeared elevated at 3.9x LTM in late 2025 due to cyclically depressed earnings, the company has successfully termed out debt at attractive fixed rates. Management expects leverage to naturally deleverage to below 3.0x over the next four to six quarters as EBITDA recovers. This strong cash conversion profile provides flexibility for capital allocation, including potential share repurchases or accretive M&A in a fragmented market where private valuations are resetting.

Shares recently traded at approximately $16, implying a valuation of roughly 6.9x estimated 2026 EBITDA and a normalized FCF yield to equity approaching 25%. This valuation reflects a market consensus that likely underestimates the pace of the recovery in bill-pay spreads and volume demand. As the cycle turns and margins normalize toward historical averages, the disconnect between the current share price and the company’s intrinsic earnings power presents a compelling asymmetry, with potential for material upside as operating leverage takes hold and sentiment realigns with business fundamentals.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

First name:

Last name:

Email address:

City / state / country:

Company:

How did you hear about MOI Global? Select Member referral Staff This website Media / Internet Other

If referral, please provide member's name:

Which of the following applies most closely to you? Select Investment Firm - Head Investment Firm - Analyst or PM Institutional Allocator - Firm C-Level Executive Institutional Allocator - Firm Employee Family Office - Head or Co-Owner Family Office - Employee Non-Investment Firm - C-Level Executive Non-Investment Firm - Employee Other

How do you hope to add value to the community?

Leave this field empty if you're human:

About the instructor:

Kyle Mowery is the founder and managing partner of GrizzlyRock Capital. Kyle holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from UCLA. GrizzlyRock takes a fundamental, value-oriented research approach focused on finding clarity within complexity in small cap companies. GrizzlyRock’s rigorous research and structured investment process provides a sturdy foundation for systematically identifying substantially mispriced securities with high risk/reward asymmetry.